Breast imaging is the foundation of breast cancer early detection. We are interested in the ways that quantitative approaches can be applied to identify features on imaging that are associated with breast cancer. This is especially important for those with a higher-than-average risk, such as cancer survivors. A particular focus is the measurement of “background parenchymal enhancement” (BPE), which reflects the metabolic activity of the breast and may predict the risk of future breast cancer.
